1. SLCO1B1,SLCO2B1, andSLCO1B3Polymorphisms and Susceptibility to Bladder Cancer Risk
   Hoai Thi Thu Bui et al, 2014, Cancer Investigation CrossRef
2. Preventive effect of intravesical ozone supplementation on n-methyl-n-nitrosourea-induced non-muscle invasive bladder cancer in male rats
   Kerem Teke et al, 2017, Experimental Animals CrossRef
3. Comparative proteomic analyses of urine from rat urothelial carcinoma chemically induced by exposure to N-butyl-N-(4-hydroxybutyl)-nitrosamine
   Rita Ferreira et al, 2015, Molecular BioSystems CrossRef
4. Animal models of urinary bladder cancer and their application to novel drug discovery
   Paula A Oliveira et al, 2014, Expert Opinion on Drug Discovery CrossRef
5. Challenges within vitroandin vivoexperimental models of urinary bladder cancer for novel drug discovery
   P. A. Oliveira et al, 2016, Expert Opinion on Drug Discovery CrossRef
6. Bladder cancer-induced skeletal muscle wasting: Disclosing the role of mitochondria plasticity
   Ana Isabel Padrão et al, 2013, The International Journal of Biochemistry & Cell Biology CrossRef
7. Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics
   Céu Costa et al, 2015, PLOS ONE CrossRef
8. Modeling human bladder cancer
   Cassandra Ringuette-Goulet et al, 2018, World Journal of Urology CrossRef
9. Anticancer effect of salidroside reduces viability through autophagy/PI3K/Akt and MMP‑9 signaling pathways in human bladder cancer cells
   Tian Li et al, 2018, Oncology Letters CrossRef